XML 123 R83.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Benefit Plans (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Defined Benefit Plan Disclosure [Line Items]      
Employee benefit plan contribution from Pfizer Inc. $ 8 $ 10  
Pension and other postretirement benefit expense 13 14 $ 15
Actuarial losses 32 21  
Actuarial losses, net of tax 22 13  
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]      
Service cost 6 7 7
Interest cost 3 3 3
Expected return on plan assets (3) (3) (3)
Amortization of net (gains) / losses 1 1 1
Settlement and curtailments (gains) / losses 0 (1) 1
Net periodic benefit cost 7 7 9
Company contributions 5 5  
Contribution expense $ 46 43 38
Matching percentage 100.00%    
Maximum matching percentage 5.00%    
Additional contribution percentage, minimum 0.00%    
Additional contribution percentage, maximum 8.00%    
Derivative Instruments, Gain (Loss) Reclassification from Accumulated OCI to Income, Estimated Net Amount to be Transferred $ 1    
Other Pension Plan, Postretirement or Supplemental Plans      
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]      
Contribution expense 12 2  
United States      
Defined Benefit Plan Disclosure [Line Items]      
Total cost of service credit continuation $ 38    
Installment period 10 years    
Pension and other postretirement benefit expense $ 6 6  
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]      
2020 4    
2021 4    
2022 4    
Postretirement benefit expense 4 $ 4 $ 4
United States | Pfizer      
Defined Benefit Plan Disclosure [Line Items]      
Remaining total cost $ 25    
Foreign Plan      
Defined Benefit Plan Disclosure [Line Items]      
Period of amortization 11 years 10 months 24 days    
Defined Benefit Plan, Net Periodic Benefit Cost (Credit) [Abstract]      
Expected contribution in 2020 $ 6    
2020 3    
2021 3    
2022 5    
2023 4    
2024 5    
Thereafter $ 39